Summary
The Pharmaceuticals in Europe industry profile is an essential resource for top-level data and analysis covering the pharmaceuticals industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information.
Scope
- Contains an executive summary and data on value, volume and/or segmentation
- Provides textual analysis of the industry's recent performance and future prospects
- Incorporates in-depth five forces competitive environment analysis and scorecards
- Includes a five-year forecast of the industry
- The leading companies are profiled with supporting key financial metrics
- Supported by the key macroeconomic and demographic data affecting the market
Highlights
- Detailed information is included on market size, measured by value and/or volume
- Five forces scorecards provide an accessible yet in depth view of the market's competitive landscape
- Market shares are covered by manufacturer or brand
Why you should buy this report
- Spot future trends and developments
- Inform your business decisions
- Add weight to presentations and marketing materials
- Save time carrying out entry-level research
Market Definition
The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2006 annual average exchange rates.
For the purpose of this report Europe comprises Belgium, the Czech Republic, Denmark, France, Germany, Hungary, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden and the UK.
|
Content
- Executive Summary
- Chapter 1 Market Overview
- 1.1 Market Definition
- 1.2 Research Highlights
- 1.3 Market Analysis
- Chapter 2 Market Value
- Chapter 3 Market Segmentation I
- Chapter 4 Market Segmentation Ii
- Chapter 5 Market Share
- Chapter 6 Five Forces Analysis
- 6.1 Summary
- 6.2 Buyer Power
- 6.3 Supplier Power
- 6.4 New Entrants
- 6.5 Substitutes
- 6.6 Rivalry
- Chapter 7 Leading Companies
- 7.1 Sanofi-Aventis
- 7.2 Pfizer Inc
- 7.3 Glaxosmithkline Plc
- 7.4 Astrazeneca Plc
- Chapter 8 Market Forecasts
- 8.1 Market Value Forecast
- Chapter 9 Macroeconomic Indicators
- Chapter 10 Appendix
- 10.1 Methodology
- 10.2 Industry Associations
- 10.3 Related Datamonitor Research
- List Of Tables
- Table 1: Europe Pharmaceuticals Market Value: $ Million, 2003-2007
- Table 2: Europe Pharmaceuticals Market Segmentation I: % Share, By Value, 2007
- Table 3: Europe Pharmaceuticals Market Segmentation Ii: % Share, By Value, 2007
- Table 4: Europe Pharmaceuticals Market Share: % Share, By Value, 2007
- Table 5: Key Facts: Sanofi-Aventis
- Table 6: Key Financials: Sanofi-Aventis
- Table 7: Key Facts: Pfizer Inc
- Table 8: Key Financials: Pfizer Inc
- Table 9: Key Facts: Glaxosmithkline Plc
- Table 10: Key Financials: Glaxosmithkline Plc
- Table 11: Key Facts: Astrazeneca Plc
- Table 12: Key Financials: Astrazeneca Plc
- Table 13: Europe Pharmaceuticals Market Value Forecast: $ Million, 2007-2012
- Table 14: Europe Exchange Rate, 2003
|